259 related articles for article (PubMed ID: 21294673)
21. Breast cancer incidence and hormone replacement therapy: results from the MISSION study, prospective phase.
Espié M; Daures JP; Chevallier T; Mares P; Micheletti MC; De Reilhac P
Gynecol Endocrinol; 2007 Jul; 23(7):391-7. PubMed ID: 17701770
[TBL] [Abstract][Full Text] [Related]
22. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
[TBL] [Abstract][Full Text] [Related]
23. Hormone replacement therapy use and variations in the risk of breast cancer.
Opatrny L; Dell'Aniello S; Assouline S; Suissa S
BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
[TBL] [Abstract][Full Text] [Related]
24. An analysis of the effect of selection bias on the association of hormone replacement therapy and breast cancer risk.
Csizmadi I; Friedenreich CM; Bryant HE; Courneya KS
Chronic Dis Can; 2005; 26(2-3):73-9. PubMed ID: 16251013
[TBL] [Abstract][Full Text] [Related]
25. Body size changes in relation to postmenopausal breast cancer among women on Long Island, New York.
Eng SM; Gammon MD; Terry MB; Kushi LH; Teitelbaum SL; Britton JA; Neugut AI
Am J Epidemiol; 2005 Aug; 162(3):229-37. PubMed ID: 15987723
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for breast cancer in elderly women.
Sweeney C; Blair CK; Anderson KE; Lazovich D; Folsom AR
Am J Epidemiol; 2004 Nov; 160(9):868-75. PubMed ID: 15496539
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
28. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
29. Early-life physical activity and postmenopausal breast cancer: effect of body size and weight change.
Shoff SM; Newcomb PA; Trentham-Dietz A; Remington PL; Mittendorf R; Greenberg ER; Willett WC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):591-5. PubMed ID: 10868694
[TBL] [Abstract][Full Text] [Related]
30. [Replacement therapy in menopause and risk for breast tumors].
Franceschi S
Ann Ist Super Sanita; 1997; 33(2):207-11. PubMed ID: 9470242
[TBL] [Abstract][Full Text] [Related]
31. Influence of postmenopausal hormone replacement therapy on an estrogen metabolite biomarker of risk for breast cancer.
Alvarez-Vasquez RB; Axelrod D; Frenkel K; Newman MC; Sepkovic DW; Bradlow HL; Zumoff B
Horm Metab Res; 2003 Jun; 35(6):358-61. PubMed ID: 12920658
[TBL] [Abstract][Full Text] [Related]
32. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
33. Hormone replacement therapy is associated with a decreased prevalence of peripheral arterial disease in postmenopausal women.
Rockman CB; Maldonado TS; Jacobowitz GR; Adelman MA; Riles TS
Ann Vasc Surg; 2012 Apr; 26(3):411-8. PubMed ID: 22285341
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer after hormone replacement therapy--does prognosis differ in perimenopausal and postmenopausal women?
Baumgärtner AK; Häusler A; Seifert-Klauss V; Schuster T; Schwarz-Boeger U; Kiechle M
Breast; 2011 Oct; 20(5):448-54. PubMed ID: 21652211
[TBL] [Abstract][Full Text] [Related]
35. Population attributable risk of modifiable risk factors associated with invasive breast cancer in women aged 45-69 years in Queensland, Australia.
Wilson LF; Page AN; Dunn NA; Pandeya N; Protani MM; Taylor RJ
Maturitas; 2013 Dec; 76(4):370-6. PubMed ID: 24113278
[TBL] [Abstract][Full Text] [Related]
36. Weight, height, body mass index and risk of breast cancer in postmenopausal women: a case-control study.
Montazeri A; Sadighi J; Farzadi F; Maftoon F; Vahdaninia M; Ansari M; Sajadian A; Ebrahimi M; Haghighat S; Harirchi I
BMC Cancer; 2008 Sep; 8():278. PubMed ID: 18826621
[TBL] [Abstract][Full Text] [Related]
37. Estrogen metabolism genotypes, use of long-term hormone replacement therapy and risk of postmenopausal breast cancer.
Cerne JZ; Novakovic S; Frkovic-Grazio S; Pohar-Perme M; Stegel V; Gersak K
Oncol Rep; 2011 Aug; 26(2):479-85. PubMed ID: 21567099
[TBL] [Abstract][Full Text] [Related]
38. Evolution of breast cancer incidence in relation to hormone replacement therapy use in Belgium.
Antoine C; Ameye L; Moreau M; Paesmans M; Rozenberg S
Climacteric; 2011 Aug; 14(4):464-71. PubMed ID: 21545271
[TBL] [Abstract][Full Text] [Related]
39. The risk of breast cancer linked to menopausal hormone therapy.
Sæther S; Bakken K; Lund E
Tidsskr Nor Laegeforen; 2012 Jun; 132(11):1330-4. PubMed ID: 22717857
[TBL] [Abstract][Full Text] [Related]
40. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies.
Keum N; Greenwood DC; Lee DH; Kim R; Aune D; Ju W; Hu FB; Giovannucci EL
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25757865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
